Your browser doesn't support javascript.
loading
Serological response and immune-related adverse events following COVID-19 vaccination in cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.
Wang, Yue; Chen, Dong; Pan, Yuancan; Li, Haiming; Zhao, Weizhe; Lu, Taicheng; Kong, Weijia; Ding, Min; Wang, Xiaomin; Zhang, Ganlin.
  • Wang Y; School of Graduates, Beijing University of Chinese Medicine, Beijing, China.
  • Chen D; Department of Oncology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
  • Pan Y; Department of Oncology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
  • Li H; Department of Oncology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
  • Zhao W; Department of Oncology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
  • Lu T; School of Graduates, Beijing University of Chinese Medicine, Beijing, China.
  • Kong W; School of Graduates, Beijing University of Chinese Medicine, Beijing, China.
  • Ding M; Department of Oncology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
  • Wang X; School of Graduates, Beijing University of Chinese Medicine, Beijing, China.
  • Zhang G; Department of Oncology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
Rev Med Virol ; 34(1): e2495, 2024 Jan.
Article en En | MEDLINE | ID: mdl-38017632

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Neoplasias Tipo de estudio: Systematic_reviews Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Neoplasias Tipo de estudio: Systematic_reviews Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article